Search Results

, characteristic imaging [LI-RADS 5] or histopathologic confirmation). 25 We excluded patients (1) with liver masses without characteristic imaging or histology, (2) for whom the date of HCC presentation and/or diagnosis could not be ascertained from the

resection of the primary tumor, in consideration of postoperative recurrence and poor prognosis due to the high rate of occult cervical metastasis in early OSCC. 13 Because of the lack of consensus in characteristics, study populations, and patient

.8% Hispanic, 7.8% African American, and 10.5% Asian. The characteristics of the study population are shown in Table 2 . Patients experienced a range of 16- to 77-week delays (median, 24 weeks) to initiating chemotherapy treatment. For 75% of patients, the

, Patient Characteristics, and Treatment Identification This study identified all women older than 65 years diagnosed with ovarian cancer (n=26,379) in SEER cancer registries from January 1, 1995, to December 31, 2007. Women were excluded if they had a

the burden of cancer on mortality for patients with NETs remains scarce. NETs are a heterogeneous malignancy with variable biologic, clinical, and prognostic characteristics. There is an evolving need to adapt treatment plans to their unique biology

. Analyses were conducted using SAS 9.4 (SAS Institute Inc). Results Cohort Characteristics Of the 21,500 patients in the study cohort, 11,298 (52.5%) presented with metastatic disease, 3,092 (14.4%) were in the resectable group, and 7,110 (33.1%) were in the

believed prohibited informed consent or study participation. Study Measures Sociodemographic and Clinical Characteristics Participants completed a demographic questionnaire to report their race, relationship status, work status, education level, annual

-Medicare linkage, patient follow-up was through December 2014. Statistical Analysis Baseline characteristics were compared using the chi-square or Wilcoxon rank-sum test. Multivariable logistic regression was used to identify predictors for receiving cisplatin

extended to 90 days before the first vaccine dose. Early symptom onset was defined as an adverse event within 24 hours of vaccination. Baseline characteristics of the study population were tabulated separately for patients without cancer, unselected

for GA impairment and construction of the CARE Frailty Index are provided in supplemental eAppendices 1 and 2 . Statistical Analysis We compared baseline characteristics between the 3 age groups (60–64, 65–74, and ≥75 years) using appropriate